VOYA Investment Management
CMPX icon

VOYA Investment Management’s Compass Therapeutics CMPX Stock Holding History

VOYA Investment Management’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.3K Sell
27,069
-348,251
-93% -$1.03M ﹤0.01% 2426
2026
Q1 		$1.99M Buy
375,320
+352,691
+1,559% +$2.04M ﹤0.01% 1190
2025
Q4 		$122K Buy
22,629
+5,415
+31% +$25K ﹤0.01% 2234
2025
Q3 		$60.2K Sell
17,214
-9,945
-37% -$31.4K ﹤0.01% 2367
2025
Q2 		$70.6K Sell
27,159
-2,329
-8% -$4.8K ﹤0.01% 2551
2025
Q1 		$56K Sell
29,488
-3,073
-9% -$8.17K ﹤0.01% 2529
2024
Q4 		$47.2K Sell
32,561
-5,102
-14% -$8.47K ﹤0.01% 2691
2024
Q3 		$69.3K Buy
37,663
+8,974
+31% +$11.2K ﹤0.01% 2731
2024
Q2 		$28.7K Sell
28,689
-3,509
-11% -$5.13K ﹤0.01% 2820
2024
Q1 		$63.8K Sell
32,198
-7,358
-19% -$12.7K ﹤0.01% 2701
2023
Q4 		$61.7K Hold
39,556
– – ﹤0.01% 2829
2023
Q3 		$77.9K Buy
39,556
+2,123
+6% +$5.25K ﹤0.01% 2784
2023
Q2 		$119K Buy
+37,433
New +$118K ﹤0.01% 2738

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

VOYA Investment Management's CMPX Position: Q2 2026 in Review

VOYA Investment Management reduced its Compass Therapeutics (CMPX) stake by 93% in Q2 2026, selling an estimated $1.03M and leaving 27,069 shares worth $59.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2426.

VOYA Investment Management first reported a position in CMPX in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.99M in Q1 2026. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • VOYA Investment Management held 27,069 shares of Compass Therapeutics worth $59.3K as of Q2 2026.
  • VOYA Investment Management sold 348,251 Compass Therapeutics shares in Q2 2026, an estimated $1.03M.
  • Compass Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2426 holding.
  • VOYA Investment Management first reported a position in Compass Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • VOYA Investment Management's Compass Therapeutics position peaked at $1.99M in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.